Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Published December 22, 2021 · Recall initiated: October 12, 2021
Summary
FDA records drug Class I recall D-0280-2022, published December 22, 2021 and initiated October 12, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Terminated; Reported quantity: 52,104 glass bottles; Lot: Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teligent Pharma, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATriamcinolone Acetonide Cream USP, 0.1%, packaged in a) 15 grams tubes, NDC 52565-056-15; b) 30 grams tubes,March 30, 2022
- FDADesoximetasone Ointment USP, 0.25%, packaged in a) 100 grams tubes, NDC 52565-030-99; b) 60 grams tubes, NDCMarch 30, 2022
- FDATriamcinolone Acetonide Ointment USP, 0.5%, Net Wt. 15 grams tube, Rx Only, Teligent Pharma, Inc., Buena, NewMarch 30, 2022
- FDALidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co.,March 30, 2022
- FDADiclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA PharmaceuticalsDecember 22, 2021
- FDALidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent PharmaDecember 22, 2021
Questions about this recall
Was Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50 recalled?
Yes. FDA published recall D-0280-2022 on December 22, 2021. Reported hazard: Superpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Press Release